Press release


Antwerp, January 16th, 2024, 07:30 AM CET



Gimv acts as co-lead investor in a €30M Series C financing
round at Onera Health
Onera Health, pioneer and leader in remote sleep diagnostic and monitoring
solutions enabling clinicians to conduct sleep studies anytime, anywhere,
announces the completion of a Series C financing round, , led by EQT Life Sciences,
co-led by Gimv and supported by existing investors Innovation Industries, Invest-NL,
Imec.xpand, BOM, and 15th Rock.

Onera Health focuses on breakthrough sleep Michaël Vlemmix and Sandy Blin, Partner and
testing solutions that are quick, convenient, Analyst in the Gimv Life Sciences platform,
and clinically accurate. The user-centric jointly indicate: “Onera Health is run by a highly
technology of their polysomnography (PSG) skilled management team that has been able
system brings clinical-grade PSG diagnostics to further leverage cutting edge technology
and monitoring directly to the patient’s bed which stems from the Imec research center. We
while being in the comfort of their own home believe the company’s solution has the
(hPSG). The MedTech and Digital Health potential to disrupt the sleep testing market by
company is currently operating in the United bringing complex polysomnography studies at
States, the Benelux, and the DACH region. home, which will reduce the patient backlog in
hospitals and facilitate the diagnosis of sleep
This Series C financing round allows Onera diseases which incidence is steadily increasing
Health to accelerate manufacturing and sales every year. Together with a solid international
to meet the growing customer demand for its investor base, we are thus looking forward to
innovative, self-applied, no-wire end-to-end supporting the development of such a
solution. Furthermore, the company has the breakthrough solution.”
clear ambition to become the leader in hPSG
within the field of sleep medicine via its next- Bram Vanparys, Managing Partner – Head of
generation PSG system for which clearance Life Sciences at Gimv, adds: ”The mission of
procedures are pending in Europe and the Gimv’s Life Sciences platform is to invest in
United States. companies that develop products that
positively impact our wellbeing and, in parallel
improve the efficiency of our healthcare
system. Onera Health is a perfect example of
how innovative technology leads to more
efficient diagnosis which will benefit both the
patient and the affordability of healthcare.”

For more information, please read the full press
release from Onera Health attached.




- Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - 1
Antwerp, January 16th, 2024, 07:30 AM CET Press release




About Gimv

Gimv is a European investment company, listed
on Euronext Brussels and part of the Euronext BEL
ESG Index. With over 40 years' experience in
private equity, Gimv currently has EUR 1.6 billion of
assets under management. The portfolio contains
around 60 portfolio companies, with combined
turnover of EUR 3.7 billion and more than 20,000
employees.

As a recognized market leader in selected
investment platforms, Gimv identifies
entrepreneurial, innovative companies with high
growth potential and supports them in their
transformation into market leaders. Gimv's five
investment platforms are Consumer, Healthcare,
Life Sciences, Smart Industries and Sustainable
Cities.

In Life Sciences, Gimv focuses on European R&D-
focused companies developing breakthrough
solutions that have a positive impact on human
health, from early preclinical proof of concept
through to late-stage clinical trials.

Further information on Gimv can be found on
www.gimv.com.

For further information please contact:

Michael Vlemmix, Partner Life Sciences
T +32 3 290 21 77 – michael.vlemmix@gimv.com




- Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - 2
Onera raises over €30M in Series C funding

Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a
€30M ($32M) Series C financing round. The all-equity round was led by EQT
Life Sciences and co-led by Gimv, with existing investors Innovation Industries,
Invest-NL, imec.xpand, BOM, and 15th Rock participating.

Eindhoven – January 16, 2024 – Onera Health, pioneer and leader in remote sleep diagnostic
and monitoring solutions enabling clinicians to conduct sleep studies anytime, anywhere,
announced the completion of its Series C financing round. This latest funding round brings
Onera’s total investment to date to more than €55 million.
The round was led by new investor EQT Life Sciences, investing from its EQT Health
Economics 3 fund, co-led by new investor Gimv, and joined by existing investors, including
Innovation Industries, Invest-NL, imec.xpand, BOM, and 15th Rock.

This strong backing will allow the company to accelerate manufacturing and deployment plans
to meet the growing customer demand for its innovative, self-applied, no-wire end-to-end
solution. Furthermore, the company intends to use the funds to expedite the clearance of the
second generation of its polysomnography (PSG) system in Europe and the United States,
further underlining the ambition to position itself as a leader in home PSG (hPSG) within the
field of sleep medicine.

“We are delighted that two premier Life Sciences investors, as well as our existing world-class
investors, have the confidence to join and support us in the next phase of our company journey,”
said Ruben de Francisco, Founder and CEO of Onera Health. “This capital infusion will accelerate
our ability to scale in the US and Europe. We will continue aggressively investing in R&D, customer
success, and geographic expansion to help the medical field provide the much-needed answers for
millions of people affected by sleep disorders. We are incredibly proud and humbled by our success
to date and look forward to driving growth together with our new partners.”

Drew Burdon, Partner at EQT Life Sciences, said: “Onera Health, with its disruptive medical
technology, is a perfect fit for the EQT Health Economics strategy. We are dedicated to growing
companies with the potential to have a meaningful impact on society, and Onera is strongly aligned
with this mission. The company demonstrated a very strong product-market fit with great potential
to improve the quality of patient care while also positively impacting the cost of healthcare. We
could not be more thrilled to be supporting the next phase of their journey.”

“Gimv’s Life Sciences' partnership with Onera Health is driven by the shared commitment to
addressing unmet clinical needs. Onera is perfectly positioned to support the continued growth
potential of hospital-quality care at the patient’s home through its innovative sleep diagnostic
solution. With its top-notch team and innovative patch-based technology, we believe Onera can and
will democratize the gold-standard in sleep medicine,” Michaël Vlemmix, Partner at Gimv Life
Sciences.



Onera Technologies B.V.
Contact: Swea Ann Hagenhoff
E: media@onerahealth.com
Onera Health focuses on breakthrough sleep testing solutions that are quick, convenient, and
clinically accurate. The user-centric technology of their PSG system brings clinical-grade PSG
diagnostics and monitoring directly to the patient’s bed— in the comfort of their own home.
The MedTech and Digital Health company operates in the U.S., the Benelux, and the DACH
region.

As part of this transaction, Drew Burdon and Michaël Vlemmix will join Onera Health’s Board
of Directors.

Next month, Onera Health will showcase its product and discuss its impact at the AASM
(American Academy of Sleep Medicine) event ‘Sleep Medicine Trends 2024’ on Feb. 23–24 in
La Jolla, California.

About Onera
Onera Health is a leader in transforming sleep medicine and remote monitoring. Their
breakthrough diagnostic solutions and services are poised to help millions of people struggling
with sleep-related ailments while also impacting other medical fields by monitoring various
chronic conditions, ultimately improving the health and quality of life of patients worldwide.
The company’s innovative solutions provide comprehensive sleep test data to physicians in a
variety of clinical and non-clinical environments to optimize patient care and reduce healthcare
costs. Onera has offices in the Netherlands and the US. For more information, go to
onerahealth.com

About EQT Life Sciences
EQT Life Sciences was formed in 2022 following the integration of LSP, a leading European life
sciences venture capital firm, into the EQT platform. As LSP, the firm raised over EUR 3.0
billion and supported the growth of more than 150 companies since it started to invest over
30 years ago. With a dedicated team of highly experienced investment professionals coming
from backgrounds in medicine, science, business, and finance, EQT Life Sciences backs the
smartest inventors who have ideas that could truly make a difference for patients. The team
combines deep sector knowledge, analytical skills, and investment experience to provide the
added value that inventors seek. For more information, go to eqtgroup.com/private-
capital/life-sciences/

About Gimv
Gimv is a European investment company listed on Euronext Brussels and part of the Euronext
BEL ESG Index. With over 40 years of experience in private equity, Gimv currently has EUR
1.6 billion of assets under management. The portfolio has around 60 companies, with a
combined turnover of EUR 3.7 billion and 20,000 employees.
As a recognised market leader in selected investment platforms, Gimv identifies
entrepreneurial, innovative companies with high growth potential and supports them in their
transformation into market leaders. Gimv's five investment platforms are Consumer,
Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. In Life Sciences, Gimv
focuses on European R&D-focused companies developing breakthrough solutions that have a
positive impact on human health, from early preclinical proof of concept through to late-stage
clinical trials. For more information, go to gimv.com




Onera Technologies B.V.
Contact: Swea Ann Hagenhoff
E: media@onerahealth.com
Contact

Swea Ann Hagenhoff

E: media@onerahealth.com

P: +31 (0)40 3082177




Onera Technologies B.V.
Contact: Swea Ann Hagenhoff
E: media@onerahealth.com